Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at http://www.fivestarequities.com/ and get exclusive access to our numerous stock reports.
Dr Pepper Snapple Group Inc. (NYSE: DPS) shares gained 2.47 percent to close at $46.49 a share Wednesday. The stock traded between $45.24 and $46.82 on volume of 2.69 million shares traded. The company reported third quarter 2013 EPS of $1.01, an increase of 20 percent when compared to a year ago. Shares of Dr Pepper Snapple Group have gained approximately 5.0 percent year-to-date.
Get more information on Dr Pepper Snapple Group and free access to the in-depth equity report at: www.FiveStarEquities.com/DPS
Repros Therapeutics Inc. (NASDAQ: RPRX) shares dropped 27.73 percent to close at $17.12 a share Wednesday. The stock traded between $16.20 and $19.07 on volume of 4.80 million shares traded. The company announced that it plans to delay filing a New Drug Application for Androxal until the fourth quarter of 2014. Shares of Repros Therapeutics have gained approximately 9.0 percent year-to-date.
Get more information on Repros Therapeutics and free access to the in-depth equity report at: www.FiveStarEquities.com/RPRX
Varian Medical Systems, Inc. (NYSE: VAR) shares increased 1.58 percent to close at $78.52 a share Wednesday. The stock traded between $77.00 and $79.42 on volume of 1.16 million shares traded. The company reported company-wide revenues totaled $770 million for the fourth quarter of fiscal year 2013, an increase of 2.0 percent when compared to a year ago. Shares of Varian Medical Systems have gained approximately 12.0 percent year-to-date.
Get more information on Varian Medical Systems and free access to the in-depth equity report at: www.FiveStarEquities.com/VAR
Wyndham Worldwide Corporation (NYSE: WYN) shares declined 0.14 percent to close at $65.27 a share Wednesday. The stock traded between $63.31 and $65.43 on volume 1.58 million shares traded. The company reported revenues were $1.4 billion for the third quarter of 2013, an increase of 13 percent when compared to a year ago. Shares of Wyndham Worldwide have gained approximately 22.0 percent year-to-date.
Get more information on Wyndham Worldwide free access to the in-depth equity report at: www.FiveStarEquities.com/WYN
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Contact: Five Star Equities [email protected]